Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP220794.RAxZ2TkAIZcBwUj-_crMrad770lu6FpMHjVpxg2uG-a-Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP220794.RAxZ2TkAIZcBwUj-_crMrad770lu6FpMHjVpxg2uG-a-Y130_assertion type Assertion NP220794.RAxZ2TkAIZcBwUj-_crMrad770lu6FpMHjVpxg2uG-a-Y130_head.
- NP220794.RAxZ2TkAIZcBwUj-_crMrad770lu6FpMHjVpxg2uG-a-Y130_assertion description "[These data provide new insights into TRAIL-induced necroptosis with PARP-1 being active effector downstream of RIPK1/RIPK3 initiators and suggest that pharmacological inhibitors of RIPKs and PARP-1 could be new treatment options for immune-mediated hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP220794.RAxZ2TkAIZcBwUj-_crMrad770lu6FpMHjVpxg2uG-a-Y130_provenance.
- NP220794.RAxZ2TkAIZcBwUj-_crMrad770lu6FpMHjVpxg2uG-a-Y130_assertion evidence source_evidence_literature NP220794.RAxZ2TkAIZcBwUj-_crMrad770lu6FpMHjVpxg2uG-a-Y130_provenance.
- NP220794.RAxZ2TkAIZcBwUj-_crMrad770lu6FpMHjVpxg2uG-a-Y130_assertion SIO_000772 22814620 NP220794.RAxZ2TkAIZcBwUj-_crMrad770lu6FpMHjVpxg2uG-a-Y130_provenance.
- NP220794.RAxZ2TkAIZcBwUj-_crMrad770lu6FpMHjVpxg2uG-a-Y130_assertion wasDerivedFrom befree-20140225 NP220794.RAxZ2TkAIZcBwUj-_crMrad770lu6FpMHjVpxg2uG-a-Y130_provenance.
- NP220794.RAxZ2TkAIZcBwUj-_crMrad770lu6FpMHjVpxg2uG-a-Y130_assertion wasGeneratedBy ECO_0000203 NP220794.RAxZ2TkAIZcBwUj-_crMrad770lu6FpMHjVpxg2uG-a-Y130_provenance.